AIM ImmunoTech Inc. (AIM) stock
AIMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.15+0.00 (+0.13%)
Close on Nov 12, 2026Market cap $4.52MP/E –Yield –
AIM ImmunoTech total assets
Total assets on the balance sheet at the end of each period.
AIM ImmunoTech's total assets was $9.75M at Sep 30, 2026. For fiscal 2025 it was $5.78M, down 32.8% from the year before. Over ten years it grew -12.8% a year on average. The highest annual figure on record is $64.58M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.78M | -32.8% |
| FY2024 | Dec 31, 2024 | $8.61M | -55.6% |
| FY2023 | Dec 31, 2023 | $19.38M | -52.1% |
| FY2022 | Dec 31, 2022 | $40.49M | -29.8% |
| FY2021 | Dec 31, 2021 | $57.70M | -10.7% |
| FY2020 | Dec 31, 2020 | $64.58M | +211.2% |
| FY2019 | Dec 31, 2019 | $20.75M | +49.9% |
| FY2018 | Dec 31, 2018 | $13.85M | -2.5% |
| FY2017 | Dec 31, 2017 | $14.21M | -24.7% |
| FY2016 | Dec 31, 2016 | $18.87M | -17.2% |
| FY2015 | Dec 31, 2015 | $22.80M | -22.5% |
| FY2014 | Dec 31, 2014 | $29.44M | -7.6% |
| FY2013 | Dec 31, 2013 | $31.87M | -44.8% |
| FY2012 | Dec 31, 2012 | $57.70M | +32.6% |
| FY2011 | Dec 31, 2011 | $43.51M | -15.8% |
| FY2010 | Dec 31, 2010 | $51.68M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $9.75M | +77.5% |
| Q2 FY2026 | Jun 30, 2026 | $12.73M | +208.3% |
| Q1 FY2026 | Mar 31, 2026 | $8.59M | +37.4% |
| Q4 FY2025 | Dec 31, 2025 | $5.78M | -32.8% |
| Q3 FY2025 | Sep 30, 2025 | $5.49M | -59.6% |
| Q2 FY2025 | Jun 30, 2025 | $4.13M | -73.7% |
| Q1 FY2025 | Mar 31, 2025 | $6.25M | -61.4% |
| Q4 FY2024 | Dec 31, 2024 | $8.61M | -55.6% |
| Q3 FY2024 | Sep 30, 2024 | $13.59M | -51.2% |
| Q2 FY2024 | Jun 30, 2024 | $15.72M | -53.3% |
| Q1 FY2024 | Mar 31, 2024 | $16.19M | -60.0% |
| Q4 FY2023 | Dec 31, 2023 | $19.38M | -58.1% |
| Q3 FY2023 | Sep 30, 2023 | $27.86M | -45.2% |
| Q2 FY2023 | Jun 30, 2023 | $33.62M | -37.9% |
| Q4 FY2022 | Dec 31, 2022 | $40.49M | -29.8% |
| Q3 FY2022 | Sep 30, 2022 | $46.29M | -26.6% |
| Q2 FY2022 | Jun 30, 2022 | $50.88M | -23.7% |
| Q1 FY2022 | Mar 31, 2022 | $54.16M | -26.9% |
| Q4 FY2021 | Dec 31, 2021 | $57.70M | -10.7% |
| Q3 FY2021 | Sep 30, 2021 | $63.08M | -1.7% |
| Q2 FY2021 | Jun 30, 2021 | $66.72M | +33.1% |
| Q1 FY2021 | Mar 31, 2021 | $74.09M | +74.7% |
| Q4 FY2020 | Dec 31, 2020 | $64.58M | +211.2% |
| Q3 FY2020 | Sep 30, 2020 | $64.16M | +185.3% |
| Q2 FY2020 | Jun 30, 2020 | $50.12M | +263.0% |
| Q1 FY2020 | Mar 31, 2020 | $42.41M | +165.6% |
| Q4 FY2019 | Dec 31, 2019 | $20.75M | +49.9% |
| Q3 FY2019 | Sep 30, 2019 | $22.49M | +48.3% |
| Q2 FY2019 | Jun 30, 2019 | $13.81M | -12.0% |
| Q1 FY2019 | Mar 31, 2019 | $15.97M | -1.8% |
| Q4 FY2018 | Dec 31, 2018 | $13.85M | -2.5% |
| Q3 FY2018 | Sep 30, 2018 | $15.17M | +3.0% |
| Q2 FY2018 | Jun 30, 2018 | $15.69M | -2.6% |
| Q1 FY2018 | Mar 31, 2018 | $16.26M | -3.6% |
| Q4 FY2017 | Dec 31, 2017 | $14.21M | -24.7% |
| Q3 FY2017 | Sep 30, 2017 | $14.73M | -31.8% |
| Q2 FY2017 | Jun 30, 2017 | $16.11M | – |
| Q1 FY2017 | Mar 31, 2017 | $16.86M | – |
| Q4 FY2016 | Dec 31, 2016 | $18.87M | – |
| Q3 FY2016 | Sep 30, 2016 | $21.58M | – |
See a number that looks wrong?